Skip to content

Lambda-X Ophthalmics

Active Private limited companyfounded 2023active for 3 yearsAvenue Robert Schuman 102, 1400 NivellesKBO/BCE: BE 0804.389.623 subsidiary of Lesna Participations#7 company by equity in Walloon Brabant, Computer and electronic products sector
Lambda-X Ophthalmics
Follow ReportCompare

Overview

Lifetime

3 annual accounts with figures on one time axis
peak €3.2m (2025)
€3.2m▲ 2.9%
peak €1.3m (2025)
€1.3m▲ 23.1%
peak €4.0m (2024)
€4.0m▼ 0.8%
€3.1m▲ 81.0%
peak 9.6 FTE (2025)
9.6 FTE▲ 17.1%
Board10 names since 2023
3 directorsBASNCO and 2 others
Owners4 names in the annual accounts
100%Lesna Participations
Documentsfilings and deeds
29-06-202632 days before the deadline
2025abbreviated format
Staff from 8.2 FTE to 9.6 FTEDividend €1.3mDebts from €1.7m to €3.1mInvestments €1.4mCash from €215,026 to €606,698

Key points

from the 2025 annual accounts

Equity

€4.0m ▼ 0.8%
4.02024+1.3Profit-1.3Dividend4.02025

Lambda-X Ophthalmics paid out €1.3m in dividends. That is 102% of the 2025 profit.

Turnover

≈ €5.5m estimated

The accounts state no turnover.

Debts

€3.1m ▲ 81.0%
Other debts
+1.2
Suppliers
+0.2
Financial debts
+0.07
The rest
-0.1

Debts rose by €1.4m in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€1.3m 2.0 × depreciation
202320242025

Green is investment, beige is depreciation. Machinery stands 26.1% higher than in 2024.

Staff

9 employees on 31-12-2025
702023612024032025

In 2025, nobody joined and 3 people left.

Position in the sector

€1.3m

Higher net result than 95% of companies in computer and electronic products. Sector median €21,042 · 147 companies.

Checked score

94
Excellent
Financially stronger than 52% of micro companies in computer and electronic products (NACE 26)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: 0.1% across 447 companies (NACE 26, micro).

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.2% 01-2025: 0.2%● unchanged vs 12-2024 02-2025: 0.2%● unchanged vs 01-2025 03-2025: 0.2%● unchanged vs 02-2025 04-2025: 0.2%● unchanged vs 03-2025 05-2025: 0.2%● unchanged vs 04-2025 06-2025: 0.2%● unchanged vs 05-2025highest value 07-2025: 0.2%● unchanged vs 06-2025 08-2025: 0.2%● unchanged vs 07-2025 09-2025: 0.2%● unchanged vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.1%▼ -0.1 percentage points vs 06-2026 08-2026: 0.1%● unchanged vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026lowest value 11-2026: < 0.1%● unchanged vs 10-2026lowest value

Financial strength
Strong

81-14equity 56.2% of total assets
42-3short-term debt 39.6% · cash 8.6%
91=return on assets 18.0%

Score breakdown

lowers risk
Size: 9.6 FTE, total assets €7.0m
Equity €4.0m (56.2% of total assets)
Profit of €1.3m (financial year 2025)
Activity since 1996 (company founded in 2023)
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 26, micro). It does better than 57% of them on solvency, 27% on liquidity, 83% on profitability and 42% on growth.

The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 39,278 companies had the same profile as Lambda-X Ophthalmics has now. Each dot stands for 99 companies, two years later.

95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

The bankruptcy probability of Lambda-X Ophthalmics itself is lower: < 0.1% within 12 months. It rests on far more data about Lambda-X Ophthalmics than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,278 companies, not a prediction for Lambda-X Ophthalmics. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit of up to €370,000 on 30-day terms is acceptable

Liquidity is ample, with a current ratio of 1.83 (2.97 in 2024), above the usual 1.5. Short-term debt is 39.6% and cash 8.6% of total assets. 43.8% of the assets are financed with debt and provisions.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

5 signals, none raises the risk
Five signals.
lowers riskneutral
lowers risk · Size: 9.6 FTE, total assets €7.0m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €4.0m (56.2% of total assets)
NBB · annual accounts
lowers risk · Profit of €1.3m (financial year 2025)
NBB · annual accounts
lowers risk · Activity since 1996 (company founded in 2023)
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 3 filings
Deviation from the deadline
2025
32 days early
2024
52 days early
2023
22 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 3 accounts on average 35 days before the deadline. In the sector (NACE 26), the median for financial year 2024 was 8 days before the deadline, and 34% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 29 June (3 of the last 3 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
07-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since incorporation in 2023.
KBO publications

Board and ownership

B
BASNCO
Director, BASSEM Serge, since 06-09-2024
DA
DUCHATEAU Antoine
Director, since 06-09-2024
WG
Whitestone Group
Director, POUCHAIN Frédéric, since 06-09-2024
BR
BST Réviseurs d'Entreprises
Auditor, Benoit STEINIER
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0804389623
3 directors appointed, 5 resignations Resignations: Pro-Vision Management SA, P.O. Invest NV, Verhaert New-Products and Services NV, Joatics SRL and Verhaert Innovation Facilities NV · Appointments: Whitestone Group SA, DUCHATEAU Antoine and BASNCO SRL · Permanent representatives: POUCHAIN Frédéric, BASSEM Serge, Emmanuel Bois d'Enghien, Olivier Dupont, Paul Verhaert, Frederik Wouters and 2 others · General meeting of 06-09-2024 · Gazette deed
1 statutory auditor appointed BST Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Paul VERHAERT, Luc JOANNES, Olivier DUPONT and Frederik WOUTERS · General meeting of 28,11.2023 · Gazette deed
Company renamed to LXO New name: LXO · “ii.Le développement,la production,la commercialisation et l’offre de services de logiciels en ligne(Software…” (deed in French) · General meeting of 13-09-2024 · Gazette deed
All 10 events

Comparable companies

same main activity, similar in size and age
Company
Lambda-X Ophthalmics Nivelles - - 56.2% 9.6
SIMERA SENSE EUROPE Leuven - - 11.8% 0.5
Altereyes Hasselt - - 57.3% 5.8
AMS SENSORS BELGIUM Antwerp €21.2m -52.0% 64.0% 50.1
E POWER Wommelgem - - 0.8% 6.1
HOYA LENS BELGIUM Antwerp €22.8m 28.1% 22.7% 35.5
PUPIL Aalst - - 65.7% -

These companies have the same main activity as Lambda-X Ophthalmics: manufacture of computer, electronic and optical products (NACE 26700). They are comparable in size and age: total assets between €981,000 and €26m, founded between 1989 and 2020.

Official details

Source: KBO
Status
Active since 28-07-2023Normal situation
Activity
Manufacture of computer, electronic and optical productsNACE 26700
Joint committee
209White-collar workers in metal manufacturing · annual accounts 2025
Establishment unit
2.347.958.4421400 Nivelles, since 28-07-2023
Financial year end
31 December
Peppol
Reachable since 16-12-2025
Company details

Annual accounts 2025

€3.2m▲ 2.9%
€1.3m▲ 23.1%
€4.0m▼ 0.8%
€7.0m▲ 23.9%
Employeeson 31-12-2025
9▼ 25.0%
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Companies linked to Lambda-X Ophthalmics

Insights on Lambda-X Ophthalmics

Lambda-X Ophthalmics files the abbreviated format. That format states no turnover. The gross margin rose from €1.9m in 2023 to €3.2m in 2025.

Lesna Participations holds all the shares. In November 2024, five directors stepped down.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette.

Financials

Annual accounts 2025

abbreviated format, filed on 29-06-2026, 32 days before the deadline
€3.2m
▲ 2.9%
€1.2m
▼ 4.6%
€1.3m
▲ 23.1%
€2.3m
▼ 20.8%
56.2%
▼ 14.0 percentage points
1.83
▼ 1.14

The turnover shown is an estimate from the gross margin.

Turnover ≈ €5.5m. Estimated: probably between €3.7m and €9.0m.

In the rankings #7 company by equity in Walloon Brabant, Computer and electronic products sector

Balance sheet

balance sheet total €7.0m on 31-12-2025
What the company ownsHow it is paid for

in €m

in €m

Position in the sector

Compare with sector

56.2%

Higher than 58% of 148 companies in 2025.

1.83

Higher than 51% of 141 companies in 2025.

18.0%

Higher than 87% of 145 companies in 2025.

Lambda-X Ophthalmics Middle half of the sector 80% of the sector Abbreviated accounts in computer and electronic products (NACE 26)

Net result: top quarter · Equity: top quarter · Balance sheet total: top quarter · Working capital: top quarter · Staff: middle half

Staff

€128,208

Staff costs divided by the average number of full-time equivalents.

-3 people

people who joined people who left

In 2025, nobody joined and 3 people left. Training hours in 2025: 40.

Filed annual accounts

as filed with the National Bank, click a year to choose it
Line Trend202520242023
Balance sheet: assets
20/58 7.0m5.7m6.6m
20 033,77467,547
21/28 1.9m1.2m670,664
21 1.7m1.1m645,852
22/27 194,493172,66524,812
23 168,426133,603-
24 26,06739,06224,812
29/58 5.1m4.4m5.8m
3 1.2m1.5m1.2m
30/36 1.2m1.5m1.1m
37 --48,728
40/41 1.6m1.6m4.1m
40 1.2m1.3m1.3m
41 400,159280,0292.8m
50/53 1.6m1.1m-
54/58 606,698215,026491,730
490/1 129,74366,23732,272
Balance sheet: equity and liabilities
10/49 7.0m5.7m6.6m
10/15 4.0m4.0m3.0m
10/11 192,034192,034192,034
13 378,900378,900-
132 378,900378,900-
14 3.4m3.4m2.8m
15 2,3682,9123,456
16 29,1837,9837,983
160/5 29,1837,9837,983
160 7,9837,9837,983
164/5 21,200--
17/49 3.1m1.7m3.6m
42/48 2.8m1.5m3.3m
43 87,77113,840531,779
430/8 87,77113,840531,779
44 877,576663,1452.3m
440/4 877,576663,1452.3m
46 362,596484,903410,039
45 157,960230,53268,749
450/3 1,57199,543834
454/9 156,389130,98967,914
47/48 1.3m92,302-
492/3 263,661201,858259,488
Income statement
76A -427,697-
9900 3.2m3.1m1.9m
62 1.2m924,003563,624
630 673,825396,961240,308
631/4 19,906-2,710
635/8 21,200-7,983
640/8 1052,916130
66A 8,606482,044110,502
9901 1.2m1.3m978,175
75/76B 61,74551,95415,583
75 61,74551,95415,583
65/66B 99,86757,11666,266
65 99,86757,11666,266
9903 1.2m1.3m927,492
67/77 -91,049239,160729
9904 1.3m1.0m926,763
689 -378,900-
9905 1.3m652,725926,763
Appropriation of the result
9906 4.7m3.4m926,763
14P 3.4m2.8m-
791/2 --1.8m
694/7 1.3m--
694 1.3m--
Social balance sheet
9087 9.68.25.7
Hours worked1013 16,87613,74410,088
Document PDFPDFPDF

The notes to these accounts have 18 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.

Source: Annual accounts 2025 at the NBB, filed on 29-06-2026.

Download as CSV

Filings

each dot is a set of accounts, on the day it reached the National Bank
Financial year Type Filed Reference Document
31-12-2025 abbreviated format 29-06-2026 2026-00249467 PDF
31-12-2024 full format 09-06-2025 2025-00138039 PDF
31-12-2023 full format 09-07-2024 2024-00230561 PDF

Key figures and ratios

per financial year, computed from the annual accounts
Line Trend202520242023
1.9m1.7m1.2m
1.9m1.4m1.2m
1.3m937,0614.9m
391,672-276,704-
2.3m2.9m2.5m
56.2%70.2%45.0%
1.832.971.74
1.411.981.39
0.770.421.22
32.1%25.9%31.3%
18.0%18.2%14.1%
18.9329.2918.39

EBIT margin: not included in this filing.

A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.

Social balance sheet

Item31-12-202531-12-202431-12-2023
Employees at the balance-sheet date9127
full-time797
part-time23-
in full-time equivalents8.611.27
9.68.25.7
On a permanent contract9127
Joined067
Left310
Training hours4088-

Source: social balance sheet in the 2023 to 2025 annual accounts

Securities and guarantees

on own assets and for others
Item202520242023
Debts secured on the company's own assets€87,771€13,840€531,779
€1.0m€1.0m€1.0m

Source: notes to the 2023 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)

Investments

fixed assets acquired
Item202520242023
Tangible fixed assets€80,132€174,144€224,067
Intangible fixed assets€1.3m€762,916€4.6m
€673,825€396,961€240,308

Source: notes to the 2023 to 2025 annual accounts (statement of fixed assets)

Insights on Lambda-X Ophthalmics

The operating result for 2025 is 5% lower than in 2024.

Debt's share of the balance-sheet total rises from 29.7% to 43.4%. Equity is lower and debt is higher.

Board & ownership

Board

3 directors, 1 auditor, no change since 2024
BASNCO BV
Director, permanent representative BASSEM Serge
since 06-09-2024
also on the board of 1 other company
listed in the 2025 annual accounts, filed on 29-06-2026
DUCHATEAU Antoine
Director
since 06-09-2024
listed in the 2025 annual accounts, filed on 29-06-2026
Whitestone Group NV
Director, permanent representative POUCHAIN Frédéric
since 06-09-2024
also on the board of 8 other companies
listed in the 2025 annual accounts, filed on 29-06-2026
BST Réviseurs d'Entreprises
Statutory auditor, permanent representative Benoit STEINIER
appointed by deed of 14-10-2024
Permanent representatives 2
BASSEM Serge
Permanent representative, for BASNCO
appointed by deed of 05-11-2024
POUCHAIN Frédéric
Permanent representative, for Whitestone Group
appointed by deed of 05-11-2024

Office holders in the KBO →

Mandates through the years

10 names, the dashed line is today
BASNCO
Director
DUCHATEAU Antoine
Director
Whitestone Group
Director
BST Réviseurs d'Entreprises
Statutory auditor
JOATICS
Director (not named in the articles)
P.O. INVEST
Director (not named in the articles)
PRO-VISION MANAGEMENT
Director (not named in the articles)
Verhaert Innovation Facilities NV
Director
VERHAERT NEW-PRODUCTS & SERVICES
Director (not named in the articles)
VERHAERT CONSULTANCIES
Director (not named in the articles)
BoardEarlierend not dated
Mandates as a list
  • BASNCO
    • Director, from 06-09-2024 to date
  • DUCHATEAU Antoine
    • Director, from 06-09-2024 to date
  • Whitestone Group
    • Director, from 06-09-2024 to date
  • BST Réviseurs d'Entreprises
    • Statutory auditor, from 28-11-2023 to date
  • JOATICS
    • Director (not named in the articles), from 28-07-2023 to 05-11-2024
    • Director (not named in the articles), appointed by deed of 01-08-2023, no longer listed in the 2025 annual accounts
  • P.O. INVEST
    • Director (not named in the articles), from 28-07-2023 to 05-11-2024
    • Director (not named in the articles), appointed by deed of 01-08-2023, no longer listed in the 2025 annual accounts
  • PRO-VISION MANAGEMENT
    • Director (not named in the articles), from 28-07-2023 to 05-11-2024
    • Director (not named in the articles), appointed by deed of 01-08-2023, no longer listed in the 2025 annual accounts
  • Verhaert Innovation Facilities NV
    • Director, from 28-07-2023 to 05-11-2024
  • VERHAERT NEW-PRODUCTS & SERVICES
    • Director (not named in the articles), from 28-07-2023 to 05-11-2024
  • VERHAERT CONSULTANCIES
    • Director (not named in the articles), appointed by deed of 01-08-2023, no longer listed in the 2025 annual accounts

See the board, name and registered office on a given date →

Control

Parent
Lesna Participations
Equity €7.3m
Loss €217,964 in 2025 (loss €83,768 in 2024)
Checked score 82
Source: deed 04-08-2026
100%
This company
Lambda-X Ophthalmics
Equity €4.0m
Profit €1.3m in 2025

Further up the chainWhitestone Group 69.1%WHITESTONE PARTNERS, EN ABREGE : WP 79.35%

Capital

Contribution
€192,034.05
Shares
2,050
Contribution per share
€93.68
Equity per share
€1,931 in 2025
Source
2025 annual accounts

Owners through the years

as the annual accounts name them
Lesna Participations
100%
100%
P.O. INVEST
40%
40% until 2023
PRO-VISION MANAGEMENT
35.46%
35.46% until 2023
VERHAERT NEW-PRODUCTS & SERVICES
24.54%
24.54% until 2023
Owners as a list

Source: shareholder structure in its own accounts

Articles of association

DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 26-09-2024 (in French)
Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 3 directors
At most 4 directors
“Mandat des administrateurs, le conseil d'administration peut élire un président parmi ses membres”
deed of 26-09-2024 (in French)
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
“Moitié cédant moitié acquéreurs proportionnellement si plusieurs, exiger rachat par opposants au prix notification initiale”
deed of 01-08-2023 (in French)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May at 09:00
deed of 26-09-2024 (in French)

Capital transactions

Shareholders according to the deeds
At incorporation deed of 01-08-2023 ↗
Capital over time
  1. 26-09-2024 Capital stated in the deed · 2,050 shares
  2. 01-08-2023 Incorporation · €2,033,620.94 · 2,050 shares

Network & group

Group

Lesna Participations has 1 direct subsidiary (2025 accounts), the bar shows equity in euros
ParentLesna Participations1 holding, 1 country 2025 accounts

Belgium 1 Equity Result

  • BE Lambda - X €4.0m result €1.3m

Source: list of holdings in the 2025 accounts of Lesna Participations. Every holding stands with its own latest accounts.

Part of the group WHITESTONE PARTNERS, EN ABREGE : WP Group, risk and exposure

Earlier ties

Lambda-X High Tech
via PRO-VISION MANAGEMENT (at Lambda-X Ophthalmics, last mentioned in 2023), VERHAERT NEW-PRODUCTS & SERVICES (at Lambda-X Ophthalmics until 2024) and P.O. INVEST (at Lambda-X Ophthalmics, last mentioned in 2023) · Director · deed of 01-08-2023
founded in 2023
 43 FTE (2025)
INNOVATION FACILITIES
via PRO-VISION MANAGEMENT (at Lambda-X Ophthalmics, last mentioned in 2023), VERHAERT NEW-PRODUCTS & SERVICES (at Lambda-X Ophthalmics until 2024) and P.O. INVEST (at Lambda-X Ophthalmics, last mentioned in 2023) · deeds of 04-06-2026 and 18-05-2021
founded in 1996
 total assets €3.3m (2025)

Acquisitions and mergers

1 transaction
Received in a demerger part of:INNOVATION FACILITIES
BE 0458.269.372partial demerger · Gazette deed of 01-08-2023

Connections & network

11 connected companies
Depth
BV Capital Management, Shared corporate director BCBV CapitalManagementECOTYS, Shared corporate director EECOTYSEMULCO LABORATORIES, Shared corporate director ELEMULCOLABORATORIESFreedelity, Shared corporate director FFreedelityINSENS, Shared corporate director IINSENSNEWTREE, Shared corporate director NNEWTREEOrbistone Capital, Shared corporate director OCOrbistoneCapitalTELEMIS HOLDING, Shared corporate director THTELEMISHOLDINGTILMAN, Shared corporate director TTILMANWHITESTONE CAPITAL, Shared corporate director WCWHITESTONECAPITALWHITESTONE PROPERTIES, Shared corporate director WPWHITESTONEPROPERTIESINNOVATION FACILITIES, Shared corporate director IFINNOVATIONFACILITIESLambda-X High Tech, Shared corporate director LHLambda-X HighTechLambda-X Ophthalmics Lambda-XOphthalmics0804.389.623
Shared directors
This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
EMULCO LABORATORIES
via Whitestone Group · Director · deed of 26-10-2022
Founded in 2005 · 1.8 FTE (2025) · negative equity
→
WHITESTONE PROPERTIES
via Whitestone Group · Director · deed of 30-05-2022
Founded in 2020 · total assets €929,812 (2025) · negative equity · group WHITESTONE PARTNERS, EN ABREGE : WP
→
TILMAN
via Whitestone Group · Class B director · deed of 25-06-2024
Founded in 1996 · 212 FTE (2025)
→
NEWTREE
via Whitestone Group · Director · deed of 03-04-2025
Founded in 2001 · total assets €24.8m (2025)
→
Show 7 more companies with a shared director
TELEMIS HOLDING
via Whitestone Group · Director · deed of 13-02-2025
Founded in 2012 · total assets €14.2m (2026)
→
ECOTYS
via Whitestone Group · Director · deed of 11-09-2025
Founded in 2008 · total assets €13.3m (2025) · group WHITESTONE PARTNERS, EN ABREGE : WP
→
WHITESTONE CAPITAL
via Whitestone Group · Director (not named in the articles) · deed of 20-10-2021
Founded in 2021 · total assets €5.0m (2025) · group WHITESTONE PARTNERS, EN ABREGE : WP
→
Freedelity
via Whitestone Group · Director · deed of 26-06-2026
Founded in 2009 · 12 FTE (2025)
→
INSENS
via BASNCO · Director (not named in the articles) · deed of 23-10-2024
Founded in 2019 · 5.1 FTE (2025)
→
BV Capital Management
via Whitestone Group · Director · deed of 21-04-2026
Founded in 2021 · total assets €254,919 (2025)
→
Orbistone Capital
via Whitestone Group · Director · deed of 23-10-2026
Founded in 2026
→

Timeline

Timeline

10 events since 2023

Deadline for the 2026 accounts: 31-07-2027

2026
Annual accounts 2025 filed NBBabbreviated format · 32 days before the deadline
2025
Highest result from 2023 to 2025 net €1.3m ▲23.1% The net result of €1.3m is the highest of those years.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0804389623
Annual accounts 2024 filed PDFfull format · 52 days before the deadline
2024
3 directors appointed, 5 resignationsResignations: Pro-Vision Management SA, P.O. Invest NV, Verhaert New-Products and Services NV, Joatics SRL and Verhaert Innovation Facilities NV · Appointments: Whitestone Group SA, DUCHATEAU Antoine and BASNCO SRL · Permanent representatives: POUCHAIN Frédéric, BASSEM Serge, Emmanuel Bois d'Enghien, Olivier Dupont, Paul Verhaert, Frederik Wouters and 2 others · General meeting of 06-09-202418 points ▸
  • General meeting, 06-09-2024
  • Director resignation, Pro-Vision Management SA
  • Director resignation, P.O. Invest NV
  • Director resignation, Verhaert New-Products and Services NV
  • Director resignation, Joatics SRL
  • Director resignation, Verhaert Innovation Facilities NV
  • Director appointment, Whitestone Group SA
  • Permanent representative, POUCHAIN Frédéric
  • Director appointment, DUCHATEAU Antoine
  • Director appointment, BASNCO SRL
  • Permanent representative, BASSEM Serge
  • Power of attorney, Business Ways SA
  • Permanent representative, Emmanuel Bois d'Enghien
  • Permanent representative, Olivier Dupont
  • Permanent representative, Paul Verhaert
  • Permanent representative, Frederik Wouters
  • Permanent representative, Luc Joannes
  • Permanent representative, Koen Verhaert

Open the deed in the Belgian Official Gazette

1 statutory auditor appointedBST Réviseurs d'Entreprises (statutory auditor) · Permanent representatives: Paul VERHAERT, Luc JOANNES, Olivier DUPONT and Frederik WOUTERS · General meeting of 28,11.20236 points ▸
  • Auditor appointment, BST Réviseurs d'Entreprises (statutory auditor)
  • Permanent representative, Paul VERHAERT
  • Permanent representative, Luc JOANNES
  • Permanent representative, Olivier DUPONT
  • Permanent representative, Frederik WOUTERS
  • General meeting, 28,11.2023
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

Company renamed to LXONew name: LXO · “ii.Le développement,la production,la commercialisation et l’offre de services de logiciels en ligne(Software…” (deed in French) · General meeting of 13-09-20245 points ▸
  • General meeting, 13-09-2024
  • Purpose change, “ii.Le développement,la production,la commercialisation et l’offre de services de logiciels en ligne(Software as a Service-SaaS)de métrologie et de simulation po…” (deed in French)
  • Name change, LXO
  • 2,050 shares
  • Power of attorney, Catherine GILLARDIN
  • The deed holds 5 more points.

Open the deed in the Belgian Official Gazette

Annual accounts 2023 filed PDFfull format · 22 days before the deadline
2023
IncorporationFounding capital of €2,033,620.94, 2,050 shares · Demerger: INNOVATION FACILITIES splits off to Lambda-X Ophthalmics · Founders: PRO-VISION MANAGEMENT, P.O. Invest and VERHAERT – NEW PRODUCTS & SERVICES · published on 01-08-202322 points ▸
  • General meeting, 28-07-2023
  • Power of attorney, PRO-VISION MANAGEMENT
  • Accounting effect, 01-01-2023
  • Registered office clause, 1400 Nivelles Avenue Robert Schuman 102
  • Board rule, 5
  • Director appointment, PRO-VISION MANAGEMENT (director (not named in the articles))
  • Director appointment, P.O. Invest (director (not named in the articles))
  • Director appointment, VERHAERT – NEW PRODUCTS & SERVICES (director (not named in the articles))
  • Director appointment, JOATICS (director (not named in the articles))
  • Director appointment, VERHAERT CONSULTANCIES (director (not named in the articles))
  • Permanent representative, DUPONT Olivier Jacques André Ernest
  • Permanent representative, VERHAERT Paul Josephus Andreas
  • Permanent representative, WOUTERS Frederik Maurits Fernand Agnes
  • Permanent representative, JOANNES Luc Claire Francis
  • Permanent representative, VERHAERT Koen Jozef Philomena
  • Founding capital, €2,033,620.94, 2,050 shares
  • Founder, PRO-VISION MANAGEMENT
  • Founder, P.O. Invest
  • Founder, VERHAERT – NEW PRODUCTS & SERVICES
  • P.O. Invest holds 820 shares
  • PRO-VISION MANAGEMENT holds 727 shares
  • VERHAERT – NEW PRODUCTS & SERVICES holds 503 shares
  • The deed holds 15 more points.

Open the deed in the Belgian Official Gazette

First establishment Avenue Robert Schuman 102, Nivelles

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

Lambda-X Ophthalmics was incorporated on 28 July 2023 as a private limited company by PRO-VISION MANAGEMENT, P.O. Invest and VERHAERT - NEW PRODUCTS & SERVICES, with a starting capital of €2.0m.12 The name was changed to LXO in 2024.3 The board currently has 3 members, 3 of whom have served since 2024.4 Total assets went from €6.6m in 2023 to €7.0m in 2025 and headcount from 5.7 to 9.6 full-time equivalents.5

  1. 1KBO register
  2. 2Belgian Official Gazette, 01-08-2023
  3. 3Belgian Official Gazette, 26-09-2024
  4. 4National Bank, annual accounts 2025
  5. 5National Bank, annual accounts 2023 and 2025

Company details

Identity

Enterprise number
0804.389.623
VAT number
BE 0804.389.623
Peppol ID
0208:0804389623
LEI code
984500E4805893E3JU61 live in the LEI register
Legal form
Private limited company
Status
Active, normal situation
Founded
28-07-2023
Financial year
ends on 31 December
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Last Friday of May at 09:00
deed of 26-09-2024 (in French)
Peppol
Reachable since 16-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
Name
Lambda-X Ophthalmics in French
Abbreviation
LXO in French
Entity type
Legal entity
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
deed of 26-09-2024 (in French)
Name clauseThe company operates under this name according to its articles.
Lambda-X Ophthalmics
deed of 26-09-2024 (in French)

Activities

NACEBEL 2025
VAT activities
26700 Manufacture of computer, electronic and optical products main activity
Social security (RSZ) activities
26700 Manufacture of computer, electronic and optical products main activity
Joint committees annual accounts 2025
JC 209 White-collar workers in metal manufacturing
Codes under NACEBEL 2008
VAT activities
26700 Manufacture of computer, electronic and optical products main activity
Social security (RSZ) activities
26700 Manufacture of computer, electronic and optical products main activity
PurposeThe purpose describes the activities the company may carry out under its articles.
“Le développement,la production,la commercialisation,la livraison et l’installation d’équipements,logiciels et accessoires de métrologie et…”
5 activities
  1. Le développement,la production,la commercialisation,la livraison et l’installation d’équipements,logiciels et accessoires de métrologie et la prestation de services d’ingénierie et de conception de systèmes d’inspection,en ce compris l’automatisation des processus,pour l’industrie ophthalmique et optique,et pour les universités,instituts de formation spécialisés,laboratoires et centres de recherche dans les secteurs ophthalmique et optique
  2. Le développement,la production,la commercialisation et l’offre de services de logiciels en ligne(Software as a Service-SaaS)de métrologie et de simulation pour l’industrie ophthalmique et optique,pour les universités,instituts de formation spécialisés,laboratoires et centres de recherche dans les secteurs ophthalmique et optique et pour les ophtalmologues et les chirurgiens ophthalmiques
  3. La livraison de services associés,qu’ils concernent toutes prestations d’étude,d’expertise,de conseil,de recherche,de formation,de qualification,de certification,et tous autres services généralement quelconques
  4. La recherche et le développement de toutes technologies se rapportant aux équipements et logiciels destinés à l’industrie ophtalmique et optique,en ce compris la robotique
  5. Le commerce en général,en ce compris l’achat,la représentation,la distribution de tous biens généralement quelconques et projets,articles et équipements se rapportant à l’objet décrit sous(i.)et toutes activités logistiques y relatives
deed of 26-09-2024 (in French)

Registered office and establishments

1 establishment
Establishment Since Unit number
Avenue Robert Schuman 102 registered office 1400 Nivelles 28-07-2023 2.347.958.442

Contact

E-mail info@lambda-x.net
Phone +32 67 47 57 31
Website www.lambda-x.com establishment in Nivelles
E-mail info@lambda-x.com establishment in Nivelles
Phone +32 67 79 40 80 establishment in Nivelles

We would like to set cookies. That happens only with your consent. What we measure